Detalhe da pesquisa
1.
Efficacy and safety of rucaparib in previously treated, locally advanced or metastatic urothelial carcinoma from a phase 2, open-label trial (ATLAS).
BMC Cancer
; 21(1): 593, 2021 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34030643
2.
A randomized phase II/III study of cabazitaxel versus vinflunine in metastatic or locally advanced transitional cell carcinoma of the urothelium (SECAVIN).
Ann Oncol
; 28(7): 1517-1522, 2017 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28419193
3.
Outcome of patients with sarcoma and other mesenchymal tumours participating in phase I trials: a subset analysis of a European Phase I database.
Ann Oncol
; 25(6): 1222-8, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24608201
4.
Prediction of early death among patients enrolled in phase I trials: development and validation of a new model based on platelet count and albumin.
Br J Cancer
; 107(7): 1025-30, 2012 Sep 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-22910320
5.
Atezolizumab in locally advanced or metastatic urothelial cancer: a pooled analysis from the Spanish patients of the IMvigor 210 cohort 2 and 211 studies.
Clin Transl Oncol
; 23(4): 882-891, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32897497
6.
SEOM clinical guideline for treatment of muscle-invasive and metastatic urothelial bladder cancer (2018).
Clin Transl Oncol
; 21(1): 64-74, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30565086
7.
Do patients with metastatic urothelial carcinoma benefit from docetaxel as second-line chemotherapy?
Clin Transl Oncol
; 16(1): 102-6, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23606355
8.
Bilateral testicular germ cell tumours: a single hospital experience.
Clin Transl Oncol
; 12(4): 299-302, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20462840